A subset of methylated CpG sites differentiate psoriatic from normal skin

Psoriasis is a chronic inflammatory immune-mediated disorder affecting the skin and other organs including joints. Over 1,300 transcripts are altered in psoriatic involved skin compared to normal skin. However to our knowledge global epigenetic profiling of psoriatic skin is previously unreported. Here we describe a genome-wide study of altered CpG methylation in psoriatic skin. We determined the methylation levels at 27,578 CpG sites in skin samples from individuals with psoriasis (12 involved, 8 uninvolved) and 10 unaffected individuals. CpG methylation of involved skin differed from normal skin at 1,108 sites. Twelve mapped to the epidermal differentiation complex, upstream or within genes that are highly up-regulated in psoriasis. Hierarchical clustering of 50 of the top differentially methylated (DM) sites separated psoriatic from normal skin samples. CpG sites where methylation was correlated with gene expression are reported. Sites with inverse correlations between methylation and nearby gene expression include those of KYNU, OAS2, S100A12, and SERPINB3, whose strong transcriptional up-regulation are important discriminators of psoriasis. We observed intrinsic epigenetic differences in uninvolved skin. Pyrosequencing of bisulfite-treated DNA from skin biopsies at three DM loci confirmed earlier findings and revealed reversion of methylation levels towards the non-psoriatic state after one month of anti-TNF-α therapy.

[1]  Wing Hung Wong,et al.  Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array. , 2003, Physiological genomics.

[2]  Guy Perrière,et al.  Between-group analysis of microarray data , 2002, Bioinform..

[3]  Mayte Suárez-Fariñas,et al.  Evaluation of the Psoriasis Transcriptome across Different Studies by Gene Set Enrichment Analysis (GSEA) , 2010, PloS one.

[4]  P. Steinert,et al.  Physical mapping of a functional cluster of epidermal differentiation genes on chromosome 1q21. , 1993, Genomics.

[5]  S. Okamoto,et al.  DNA methylation of intronic enhancers directs tissue-specific expression of steroidogenic factor 1/adrenal 4 binding protein (SF-1/Ad4BP). , 2011, Endocrinology.

[6]  B. Strober,et al.  Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial. , 2008, Journal of the American Academy of Dermatology.

[7]  Guy Perrière,et al.  MADE4: an R package for multivariate analysis of gene expression data , 2005, Bioinform..

[8]  Jeung-Hoon Lee,et al.  A global gene expression analysis of the peripheral blood mononuclear cells reveals the gene expression signature in psoriasis. , 2009, Annals of dermatology.

[9]  N. Morar,et al.  The psoriatic transcriptome closely resembles that induced by interleukin-1 in cultured keratinocytes: dominance of innate immune responses in psoriasis. , 2007, The American journal of pathology.

[10]  Ji Wu,et al.  Reproductive Biology and Endocrinology Open Access Epigenetic Regulation in Mammalian Preimplantation Embryo Development , 2022 .

[11]  K. Aagaard-Tillery,et al.  Environmental Influences on Epigenetic Profiles , 2009, Seminars in reproductive medicine.

[12]  A. Feinberg,et al.  Genome-wide methylation analysis of human colon cancer reveals similar hypo- and hypermethylation at conserved tissue-specific CpG island shores , 2008, Nature Genetics.

[13]  P. Hutchinson,et al.  Extensive plaque psoriasis successfully treated with adalimumab (Humira®) , 2005, The British journal of dermatology.

[14]  P. Soloway,et al.  A Non-Coding RNA Within the Rasgrf1 Locus in Mouse Is Imprinted and Regulated by Its Homologous Chromosome in Trans , 2010, PloS one.

[15]  J. Speakman,et al.  Role of Ucp1 enhancer methylation and chromatin remodelling in the control of Ucp1 expression in murine adipose tissue , 2010, Diabetologia.

[16]  A. Coxon,et al.  Cytosine methylation The pros and cons of DNA methylation , 1993, Current Biology.

[17]  W. Reik,et al.  Epigenetic reprogramming in mammals. , 2005, Human molecular genetics.

[18]  Jun Yao,et al.  Distinct epigenetic changes in the stromal cells of breast cancers , 2005, Nature Genetics.

[19]  A. Bowcock,et al.  Interferon α-Inducible Protein 27 (IFI27) is Upregulated in Psoriatic Skin and Certain Epithelial Cancers , 2004 .

[20]  Victor V Lobanenkov,et al.  Rasgrf1 Imprinting Is Regulated by a CTCF-Dependent Methylation-Sensitive Enhancer Blocker , 2005, Molecular and Cellular Biology.

[21]  Rafael A. Irizarry,et al.  Bioinformatics and Computational Biology Solutions using R and Bioconductor , 2005 .

[22]  Ann-Marie Broome,et al.  S100 Protein Subcellular Localization During Epidermal Differentiation and Psoriasis , 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[23]  J G Krueger,et al.  Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling , 2001, The Pharmacogenomics Journal.

[24]  W. Lam,et al.  Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells , 2005, Nature Genetics.

[25]  Andrew Johnston,et al.  Assessment of the psoriatic transcriptome in a large sample: additional regulated genes and comparisons with in vitro models. , 2010, The Journal of investigative dermatology.

[26]  Christopher B Wilson,et al.  Epigenetic control of T-helper-cell differentiation , 2009, Nature Reviews Immunology.

[27]  J. McPherson,et al.  Comprehensive DNA methylation profiling in a human cancer genome identifies novel epigenetic targets. , 2006, Carcinogenesis.

[28]  C. Griffiths,et al.  Psoriasis: epidemiology, clinical features, and quality of life , 2005, Annals of the rheumatic diseases.

[29]  A. Bowcock,et al.  Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. , 2001, Human molecular genetics.

[30]  Mary Goldman,et al.  The UCSC Genome Browser database: update 2011 , 2010, Nucleic Acids Res..

[31]  Xiao Zhang,et al.  Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis , 2010, BMC Bioinformatics.

[32]  A. Bird.  Il2 transcription unleashed by active DNA demethylation , 2003, Nature Immunology.

[33]  Gordon K. Smyth,et al.  limma: Linear Models for Microarray Data , 2005 .

[34]  B. Richardson,et al.  Epigenetics in human autoimmunity , 2008, Autoimmunity.

[35]  A. Bird.  DNA methylation patterns and epigenetic memory. , 2002, Genes & development.

[36]  W. Dean,et al.  Epigenetic reprogramming during early development in mammals. , 2004, Reproduction.

[37]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[38]  T. Ushijima,et al.  A specific CpG site demethylation in the human interleukin 2 gene promoter is an epigenetic memory , 2006, The EMBO journal.

[39]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[40]  Wei Jiang,et al.  High-throughput DNA methylation profiling using universal bead arrays. , 2006, Genome research.

[41]  D. Brutlag,et al.  A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Ronald H. Schwartz,et al.  Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process , 2003, Nature Immunology.

[43]  A. Sharp,et al.  Methylation profiling in individuals with uniparental disomy identifies novel differentially methylated regions on chromosome 15. , 2010, Genome research.

[44]  S. Ariyan,et al.  Genome-wide screen of promoter methylation identifies novel markers in melanoma. , 2009, Genome research.

[45]  A. Bowcock,et al.  Getting under the skin: the immunogenetics of psoriasis , 2005, Nature Reviews Immunology.

[46]  N. J. Eungdamrong,et al.  Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells. , 2009, The Journal of investigative dermatology.

[47]  M. Esteller,et al.  CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer , 2010, Oncogene.

[48]  J. Rogers,et al.  DNA methylation profiling of human chromosomes 6, 20 and 22 , 2006, Nature Genetics.

[49]  David Haussler,et al.  The UCSC genome browser database: update 2007 , 2006, Nucleic Acids Res..

[50]  A. Gottlieb,et al.  A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis. , 2007, Journal of the American Academy of Dermatology.

[51]  C. Nguyen,et al.  Gene expression profiles in psoriasis: analysis of impact of body site location and clinical severity , 2005, The British journal of dermatology.

[52]  Mayte Suárez-Fariñas,et al.  Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis. , 2009, The Journal of allergy and clinical immunology.

[53]  J. Travers,et al.  Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. , 2003, The Journal of allergy and clinical immunology.

[54]  G. Novelli,et al.  Evidence for differential S100 gene over-expression in psoriatic patients from genetically heterogeneous pedigrees , 2002, Human Genetics.

[55]  K A Baggerly,et al.  Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites. , 2003, BioTechniques.

[56]  James P. Curley,et al.  Epigenetic mechanisms mediating the long-term effects of maternal care on development , 2009, Neuroscience & Biobehavioral Reviews.

[57]  A. Bowcock,et al.  Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and "Type 1" inflammatory gene expression. , 2004, Trends in immunology.

[58]  W. Reik.  Stability and flexibility of epigenetic gene regulation in mammalian development , 2007, Nature.

[59]  D. Foell,et al.  Elevated serum levels of calcium‐binding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis , 2006, The British journal of dermatology.

[60]  Pan Du,et al.  lumi: a pipeline for processing Illumina microarray , 2008, Bioinform..

[61]  Donald Macleod,et al.  A fraction of the mouse genome that is derived from islands of nonmethylated, CpG-rich DNA , 1985, Cell.

[62]  A. Mutirangura,et al.  SHP-1 promoter 2 methylation in normal epithelial tissues and demethylation in psoriasis , 2006, Journal of Molecular Medicine.